Drug · DIN 02481553
XERMELO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 2, 2024; first marketed December 7, 2018.
- Drug Identification Number (DIN)
- 02481553
- Company (DIN owner)
- Serb S.A.Brussels, Brussels Capital Region, Belgium
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Telotristat A16AX15
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TELOTRISTAT ETHYL (TELOTRISTAT ETIPRATE) | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 11, 2023: NOC 29878New Drug Submission (NDS) · Administrative: Change in Product Ownership
- October 10, 2018: NOC 21406New Drug Submission (NDS)